InvestorsHub Logo
Followers 51
Posts 4564
Boards Moderated 0
Alias Born 12/14/2009

Re: None

Monday, 09/23/2019 5:10:35 PM

Monday, September 23, 2019 5:10:35 PM

Post# of 690713
"Conclusions:The addition of DCVax-L autologous dendritic cell vaccine to SOC is feasible and safe. Collectively, the blinded interim survival data suggest that the patients in this Phase 3 trial are living longer than expected. These findings warrant further follow up and analyses."

J Transl Med. 2018; 16: 142.
Published online 2018 May 29. doi: 10.1186/s12967-018-1507-6

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5975654/
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News